Purpose: The aim of this study was to verify the potential risk factors of ventilatorassociated pneumonia (VAP) in elderly Chinese patients receiving mechanical ventilation (MV). The secondary aim of this study was to present logistical regression prediction models of VAP occurrence in elderly Chinese patients receiving MV. Methods: Patients (aged 80 years or above) receiving MV for ≥48 h were enrolled from the Chinese People's Liberation Army (PLA) General Hospital from January 2011 to December 2015. A chi-squared test and Mann-Whitney U-test were used to compare the data between participants with VAP and without VAP. Univariate logistic regression models were performed to explore the relationship between risk factors and VAP. Results: A total of 901 patients were included in the study, of which 156 were diagnosed as VAP (17.3%). The incidence density of VAP was 4.25/1,000 ventilator days. Logistic regression analysis showed that the independent risk factors for elderly patients with VAP were COPD (OR =1.526, P<0.05), intensive care unit (ICU) admission (OR=1.947, P<0.01), the MV methods (P<0.023), the number of antibiotics administered (OR=4.947, P<0.01), the number of central venous catheters (OR=1.809, P<0.05), the duration of indwelling urinary catheter (OR=1.805, P<0.01) and the use of corticosteroids prior to MV (OR=1.618, P<0.05). Logistic regression prediction model of VAP occurrence in the Chinese elderly patients with mechanical ventilation:
Introduction
Ventilator-associated pneumonia (VAP) is defined as pneumonia that occurs 48-72 h (or later) following endotracheal intubation. VAP is characterized by the presence of new or progressive infiltrates, systemic infection (fever, altered white blood cell counts), changes in sputum characteristics, and the detection of a causative agent. 1 VAP is the most frequent cause of nosocomial infections amongst patients requiring mechanical ventilation (MV). 2, 3 It has been reported that the incidence of VAP is 9-27% with a mortality of 25-50%. [4] [5] [6] VAP can lead to the deterioration of a patient's condition, endanger the patient's life, and increase the health-care burden. [6] [7] [8] As the average age of the Chinese population is increasing, the number of elderly patients requiring MV is rising. Elderly patients have a compromised immune system and are more prone to opportunistic infections, increasing the likelihood of VAP. The factors affecting the occurrence of VAP are complex and diverse, making its management difficult. Specific risk factors include tracheal catheterization, MV, the duration of intensive care unit (ICU) stay, nursing measures, increased colonization of upper gastrointestinal pathogens and the aspiration of contaminated secretions. 9, 10 The risk factors for VAP in elderly patients have not been assessed in detail. Clinical practices possess no effective theoretical based evidence for the prevention of VAP in elderly patients. This study retrospectively analyzed the incidence of VAP and related risk factors in elderly patients receiving MV to provide suggestions for the prevention of VAP and elderly patient care.
Methods Participants
Elderly patients who underwent MV from the Chinese People's Liberation Army (PLA) General Hospital from January 2011 to December 2015 were included. A total of 901 patients were enrolled, including 755 males and 146 females, with an average age of (86.73 AE 4.818) years. Inclusion criteria for the study were: 1) ventilator use ≥48 h; 2) no VAP infection prior to MV; 3) ≥80 years old. Exclusion criteria were: 1) pneumonia diagnosed before MV; (2) death, ceased treatment, discharged or transferred within 48 h; (3) patients with incomplete clinical data.
Data collection
Retrospective survey methods were used to collect data on elderly patients who underwent MV from the Chinese People's Liberation Army (PLA) General Hospital from January 2011 to December 2015. The investigation was conducted with the assistance of staff from the Hospital Infection Management Section. The investigating members consisted of three nursing staff and one hospital infection management staff, all of whom received uniform training. For patients with MV, routine VAP prevention protocols were available in our hospital. All procedures involving human participants were performed in accordance with the basic principles of the Declaration of Helsinki. Ethical approval was obtained from the Beijing Municipal Commission of Science and Technology Program. Informed consent was waived due to the retrospective design. The electronic database at the Chinese People's Liberation Army General Hospital includes discharge records for all patients treated in the hospital. All patient data were anonymized and maintained with confidentiality.
Study variables
Study variables included basic patient characteristics (gender, disorder of consciousness, smoking, alcohol consumption, nutritional status, surgery, ICU admission, underlying diseases, hospitalization length of stay, ICU stay, origin of patients, duration and number of catheters), MV related data (MV methods, duration of MV and number of reintubations), and medication-related data (antibiotics use after surgery, duration of antibiotics use after surgery, number of antibiotics administered, duration of antibiotics administered, combined application of antibiotics, number of combined antibiotics administered, duration of the combined antibiotics, use of acid suppressant agent, use of sedation, and use of corticosteroids).
Diagnosis of VAP
Chest radiograph or CT showing new or progressive infiltration, consolidation, or ground glass, and at least two of the following criteria: 1) fever (>38.3°C) or hypothermic (<36°C); 2) leukocytosis (>11×10 9 /L) or leukopenia (<4×10 9 /L); and 3) purulent tracheal secretions confirmed by microscopic examination, and a quantitative bacterial cultures of 10 6 CFU/mL from an endotracheal specimens or 10 4 CFU/mL from bronchoalveolar lavage fluid. Pulmonary edema, acute respiratory distress syndrome (ARDS), tuberculosis, pulmonary embolism, and other diseases were discounted. 11 VAP rate was defined as the number of VAPs/1,000 ventilator days. 12 It can be of two types: 1) early-onset VAP, which is defined as VAP that occurs within the first 4 days of ventilation; and 2) late-onset VAP, which is defined as VAP that occurs more than 4 days after initiation of mechanical ventilation. 13 
Statistical analysis
Statistical analysis was performed using SPSS 22.0 software. The Kolmogorov-Smirnov test was used to determine the normality of distributions. Continuous variables were presented as median, max, and min, while categorical variables were presented as percentages. Mann-Whitney U-test or chi-squared test was used to compare the data between participants with VAP and participants without VAP. Univariate logistic regression models were used to analyze the risk factors of VAP. The hypothesis test significance level was 0.05. OR>1 was a risk factor and OR<1 was a protective factor. When P≤0.05 (bilateral), differences were considered statistically significant.
Quality control
According to the criteria for the inclusion and exclusion of cases, completed unified data collection forms were used to screen and collect cases that met the study criteria. Double data entries and logic verification were used to ensure data accuracy. Upon completion, all data were checked, missing data were completed, and duplicated or erroneous data were removed.
Results

VAP incidence
From January 2011 to December 2015, a total of 901 elderly patients receiving MV who met the criteria for inclusion were assessed. Of these patients, 156 had VAP (17.3%). 
Effects of MV on VAP occurrence
From 2011 to 2015, the number of elderly patients with tracheal intubation was the highest (596) and the rate of VAP was 13.4%. However, the incidence of VAP in patients with tracheotomy was 28.4%, followed by 23.7% in patients who underwent tracheotomy after tracheal intubation. Chisquared tests of the patient's MV methods revealed its influence on VAP (χ 2 =19.616, P<0.001). When the duration of ventilation between groups was compared, significant differences were observed (Z=−5.983, P<0.01). The number of MVs received also significantly influenced VAP (χ 2 =7.633, P<0.01). The incidence of VAP in patients suffering the number of reintubations >2 (28.4%) was higher than the number of reintubations ≤2 (16.2%) ( Table 3) .
Medication use
The analysis of medication use in elderly patients receiving MV in hospital showed that the use of antibiotics after surgery (χ 2 =4.652, P<0.05), the duration of (Table 5) . 
Establish logistic regression prediction model Logistic regression prediction model
Logistic regression prediction model of VAP infection in elderly patients with mechanical ventilation:
The model is used for the preliminary prediction of VAP, predicting whether VAP will occur in patients undergoing mechanical ventilation. The closer the P-value is to 1, the more likely VAP will occur in patients undergoing mechanical ventilation. The closer the P-value is to 0, the less likely the patient will have VAP.
Prediction effect evaluation of logistic regression models
The likelihood ratio test, Hosmer-Lemeshow goodnessof-fit test and receiver-operating characteristic (ROC) Discriminant ability of logistic regression equations. The ROC curve was drawn with "1-specificity" as the abscissa and "sensitivity" as the ordinate. When 0.5≤ the area under the curve (AUC) <0.7, it was considered that the discriminant value of the model was acceptable. When 0.7≤AUC<0.9, it was considered that the discriminant value of the model was favorable. When 0.9≤AUC, the value of the model was considered outstanding.
The results of this study show that the AUC of the prediction probability of the new variable was 0.722, indicating that the discriminant effect of the model was very good. The AUC of the comprehensive index was higher than that of other indices (P<0.05), indicating that the comprehensive index more accurately identified VAP, and performed better than that of the single index for the identification of VAP (Figure 1 and Table 6 ).
Discussion
VAP is a common complication during MV and a leading cause of death in MV patients. 15, 16 The clinical symptoms of VAP are complex and early diagnosis is difficult. Once VAP occurs, patients suffer difficulties withdrawing from MV, have prolonged hospitalization, increased hospitalization expenses and an increased danger to life. [6] [7] [8] Of the 901 elderly MV patients observed in this study, 156 met the diagnostic criteria for VAP (incidence=17.3%). The incidence density of VAP in our hospital was 4.25‰, which was mainly classed as late onset. This was less than previously reported values that ranged from 18% to 32%. [17] [18] [19] The incidence of VAP varied because of the target population and methods of diagnosis. In this study, the target population was elderlyChinesepatients. Analyzing the risk factors for the occurrence of VAP provides a theoretical basis for effective preventive measures. Logistic regression revealed that the risk factors of VAP in elderly patients were COPD, ICU admission, the MV methods, the number of central venous catheters, the duration of an indwelling urinary catheter, the number of antibiotics administered and the use of corticosteroids prior to MV.
MV methods are VAP risk factors
The methods of MV influenced the occurrence of VAP. The incidence of VAP was 13.4% for tracheal intubation, 28.4% for tracheostomy, and 23.7% for tracheostomy after tracheal intubation. The incidence of VAP in patients with tracheotomy was lower than that of patients who underwent tracheostomy after tracheal intubation. This is contrary to previous clinical data. Patients with MV should therefore undergo tracheotomy as quickly as possible to reduce the risk of secondary catheterization and the incidence of VAP. Wang 20 and reduce the incidence of VAP and did not shorten the duration of MV or the duration of ICU stay. This is because tracheotomy damages the normal physiological and anatomical function of the trachea. The respiratory tract directly contacts the external environment and the protective effects of upper respiratory tract filtration and humidification are weakened. This leads to a loss of cough and reflex function of the trachea, leading to pathogenic microorganisms colonizing in the tracheal tube. Colonized pathogens form biofilms, increasing the likelihood of lower respiratory tract infections.
22,23
In this study, the incidence of VAP in patients suffering >2 (28.4%) reintubations was higher than those with ≤2 (16.2%) reintubations. These differences, however, were not statistically significant. This differed from previous studies that identified reintubation as an important predictor of VAP development. [24] [25] [26] This may have been due to the number of re-intubations we compared, as opposed to the number of re-intubations that occurred. 31 The incidence of VAP varied according to the type of ICU (medical, surgical, coronary). This was higher amongst patients with burns, or in those within neurosurgical or trauma units (17-20%). 32 These findings did not agree with Torres et al, who found that the type of ICU population did not influence VAP occurrence. 33 In this study, ICU admission was the major risk factor for the occurrence of VAP. We also found that patients who developed VAP had longer ICU stays than those who did not, which was consistent with other reports. 34 ICU patients have more chronic co-existing diseases and more severe acute physiological dysfunction and suffer more invasive procedures, so they are in a state of relative immunosuppression. 3 In addition, due to the widespread use of antibiotics and improper isolation measures, cross-infection is also increasing, and the possibility of infection is increasing. Therefore, reducing the incidence of ventilator-associated pneumonia and exploring the related factors causing ventilator-associated pneumonia in ICU have been the main research focus in this field. COPD is a well-recognized risk factor for communityacquired pneumonia. 35, 36 A history of COPD has also been identified as a risk factor for VAP development. 37 The duration of MV and ICU stay were both longer in COPD patients with VAP. 38 The development of VAP in COPD patients resulted in an increase of 17% in mortality rates compared to COPD patients that did not develop VAP. 39 In this study, COPD was the major risk factor of VAP occurrence (χ 2 =6.264, P<0.05). VAP occurred in 22.6% of COPD patients, which was higher than in patients with other diseases. This may be due to the patient's advanced age, high colonization of the lower airways, the inhibition of mucociliary function due to cigarette smoking, the inability to generate an effective cough response due to airway obstruction, and the suppressive effects of corticosteroids on lung host defenses. 40 When patients with COPD develop VAP, they present an increased risk of infection of specific pathogenic bacterial species. 41 COPD leads to physiological changes which predispose patients to infections, particularly from Gram-negative bacilli. 42 
Impact of medication on the occurrence of VAP
The number of antibiotics administered by patients was a risk factor for VAP. Logistic regression showed that the incidence of VAP in patients using the number of antibiotics >3 was 4.947 times higher than those receiving ≤3, the differences of which were statistically significant. A large number of antibiotics can alter the parasitism of normal microorganisms, leading to infection by opportunistic pathogens or the emergence of drug-resistant bacterial strains, increasing the incidence of VAP. [43] [44] [45] Prior antibiotic therapy has been recognized as a risk factor for VAP in adults. 46, 47 However, it is unclear whether the number of antibiotics prolongs hospitalization or intubation, both of which are risk factors for VAP. This relationship requires further exploration and clarification. A controversial issue is the selection of antibacterials. The judicious use of appropriate antibiotics may reduce patient colonization and subsequent infections with multidrug-resistant bacteria. Data from global studies suggest that multi-resistant bacteria are increasing, but these data may not be applicable to local hospitals. Therefore, based on our knowledge of bacterial flora in our hospital, the selection of adequate therapeutic regimens will decrease both morbidity and mortality.
Reports on the effects of corticosteroids on VAP have been variable. Both experimental 48 and clinical 49 data suggest that corticosteroid use decreases the occurrence and severity of nosocomial pneumonia in patients treated in the ICU. In the case of ARDS patients, corticosteroids reduce the incidence of suspected VAP. 50, 51 A multicenter trial that included 150 intubated patients admitted to the ICU due to severe trauma showed that the use of intravenous hydrocortisone over a period of seven consecutive days resulted in a decreased risk of hospital-acquired pneumonia and an increased duration of MV-free days. 51 Mortality rates, the length of the ICU stay and the length of MV were all significantly lower in VAP patients receiving corticosteroids. 52 Alternative results have however been reported. For patients with traumatic brain injury, the use of corticosteroids failed to reduce the incidence of VAP. 53 In other studies, the use of low-dose steroids to prevent VAP was not favored. 54 However, we found that the use of corticosteroids prior to intubation in patients with MV increases the occurrence of VAP. The use of corticosteroids prior to MV was the major risk factor of VAP. The reason might be that the use of corticosteroids leads to myelosuppression, liver and kidney dysfunction, decreased immune function, and infection. In addition, corticosteroids can increase the incidence of ulcers and damage the integrity of the gastrointestinal mucosal tissue structure, leading to the adsorption and transplantation of gastrointestinal pathogens, an important risk factor of VAP. Thus, corticosteroids should be administered reasonably to elderly patients when required.
Invasive procedures influence the occurrence of VAP
The number of central venous catheters and the duration of indwelling urinary catheters were identified as risk factors for VAP. Logistic regression showed that the incidence of VAP in the number of central venous catheter >2 of patients was 1.809 times higher than those receiving ≤2, the differences of which were statistically significant. The incidence of VAP in the duration of indwelling urinary catheters >90 days of patients was 1.805 times higher than those receiving ≤90 days. Indwelling catheters bypass the host's natural defense mechanisms with high frequency, providing a method through which microbes invade important organs in the body. In the process of maintaining these catheters, medical personnel require frequent patient contact, leaving the patients vulnerable to the colonization and infection of hospital pathogens. In addition, maintenance devices act as reservoirs for pathogens, leading to the horizontal spread of pathogens between patients. 55 More regular catheters of prolonged duration is more likely to damage a patient's resistance and provide opportunities for pathogenic bacteria to enter the body, increasing the risk of infection. Therefore, invasive procedures in patients should be minimized to reduce the incidence of infection.
Establishment of VAP prediction model in elderly patients with MV
There are many factors affecting the occurrence of VAP. A model was constructed to predict the probability of VAP occurrence in patients with mechanical ventilation in Chinese elderly, to find high-risk patients infected with VAP as early as possible, to strengthen prevention measures in time, and to effectively reduce the occurrence of VAP. In this study, logistic regression was used to establish the prediction model of VAP infection in elderly patients with mechanical ventilation for the preliminary identification of VAP. By the logistic regression prediction model it is found that the number of antibiotics administered and mechanical ventilation methods have important effects on the occurrence of VAP, especially tracheotomy on the impact of VAP. Therefore, this study provides evidence for the clinical research to focus on the mechanical ventilation methods and the number of antibiotics administered to prevent VAP. This study had several potential limitations. First, this was a cross-sectional study. Only correlations rather than causal relationships were established due to the study design. Secondly, this was a single-center study and all participants were from the same tertiary hospital in China. As such, the results cannot be generalized to other demographic groups. Further multicenter, prospective cohort studies that enroll participants with different demographic characteristics are now required.
Conclusion
The incidence of VAP in elderly patients with MV was 17.3%. The incidence density of VAP was 4.25/1,000 ventilator days. The risk factors of VAP mainly include the MV methods and the number of antibiotics administered. Based on the risk factors of VAP in the elderly Chinese patients, a prediction model was established to facilitate the early detection of high-risk patients. Further multicentered, prospective cohort studies are needed.
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